SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-08-084341
Filing Date
2008-04-18
Accepted
2008-04-18 10:30:02
Documents
1
Period of Report
2008-06-04
Effectiveness Date
2008-04-18

Document Format Files

Seq Description Document Type Size
1 NOTICE & PROXY STATEMENT ddef14a.htm DEF 14A 573080
  Complete submission text file 0001193125-08-084341.txt   574531
Mailing Address 630 FIFTH AVENUE SUITE 2100 NEW YORK NY 10111
Business Address 630 FIFTH AVENUE SUITE 2100 NEW YORK NY 10111 212-994-8200
ANTIGENICS INC /DE/ (Filer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-29089 | Film No.: 08763624
SIC: 2836 Biological Products, (No Diagnostic Substances)